Psychiatry Research
May 1, 2024
Yuan Yao, Dan Guo, Tang-Sheng Lu et al.
126 citations
We aim to systematically review and meta-analyze the effectiveness and safety of psychedelics [psilocybin, ayahuasca (active component DMT), LSD and MDMA] in treating symptoms of various mental disorders. Web of Science, Embase, EBSCO, and PubMed were searched up to February 2024 and 126 articles were finally included. Results showed that psilocybin has the largest number of articles on...
Journal of Affective Disorders
February 1, 2022
Jianyu Que, Le Shi, Wei Yan et al.
Background Trauma experience increases the risk of suicidal ideation, but little is known about potentially psychological mechanisms underlying this relationship. This study aims to examine the relationship between coronavirus disease 2019 (COVID-19)-related traumatic event (CTE) exposure and suicidal ideation among hospital workers, and identify mediating roles of sleep disturbances in this...
Frontiers in Aging Neuroscience
2022
Weijian Liu, Hui Li, Xiao Lin et al.
Facial emotion recognition plays an important role in social functioning. Patients with late-life depression (LLD) often have abnormal facial emotion recognition. Mindfulness-based cognitive therapy (MBCT) is beneficial in treating depression. This study examined whether MBCT can act as an effective augmentation of antidepressants and improve facial emotion recognition in patients with LLD and...
Sleep Medicine
October 2018
Wen-Hao Chen, Jie Chen, Xiao Lin et al.
To examine changes in functional connectivity of the default mode network (DMN) that are induced by sleep deprivation, and to identify individual differences that contribute to the vulnerability of the brain's response to sleep deprivation. Using functional magnetic resonance imaging, we scanned 51 healthy young subjects during the resting state. Of these participants, 28 were scanned following...
Neuroscience Bulletin
December 2016
Weili Zhu, Zengbo Ding, Yinan Zhang et al.
Major depression is a serious psychiatric disorder and remains a leading cause of disability worldwide. Conventional antidepressants take at least several weeks to achieve a therapeutic response and this lag period has hindered their ability to attain beneficial effects in depressed individuals at high risk of suicide. The non-competitive N-methyl-D-aspartate glutamate receptor antagonist...